Evaluating New Methods to Detect Pancreatic Cancer Early with Imaging and Blood Tests

Recruiting · Pancreatic Cyst · New Jersey and New York

Check if I qualify View on ClinicalTrials.gov

About this trial

This study looks at ways to find pancreatic ductal adenocarcinoma (PDAC) early. Researchers hope to avoid the need for surgery by using imaging and blood tests. They will check if a mix of special scans and blood tests can spot PDAC in patients with pancreatic cysts. The imaging tests include an ImmunoPET scan and a hyperpolarized MRI scan.

The trial's ID number is NCT06305728. This is an FDA-regulated study looking at how well these tests work and how safe they are. The study aims to include about 25 participants.

Who can join

Men and women over 18 years old can join. Participants need to have a high-risk pancreatic cyst that requires surgery. They must be able to give informed consent. People with pancreatic cancer, pregnant or breastfeeding women, and those who cannot tolerate the scans cannot participate. The trial team will confirm who is eligible.

Condition

Pancreatic Cyst

Age group

Adult, Older adult

Sex

All sexes

The study team makes the final call on eligibility.

What happens in the study

Participants will be diagnosed with a high-risk pancreatic cyst. Those who choose to will have an ImmunoPET scan and a hyperpolarized MRI scan before surgery. Blood tests will also be done within 6 weeks of surgery and once a year after as part of follow-up care. The main goal is to see how well the ImmunoPET scan can detect cancer within a year.